Last: | $41.11 |
---|---|
Change Percent: | -0.1% |
Open: | $40.95 |
Close: | $41.11 |
High: | $41.3125 |
Low: | $40.87 |
Volume: | 2,549,243 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$41.11 | $40.95 | $41.11 | $41.3125 | $40.87 | 2,549,243 | 04-26-2024 |
$40.91 | $41.06 | $40.91 | $41.11 | $40.805 | 3,015,243 | 04-25-2024 |
$40.86 | $41.2 | $40.86 | $41.24 | $40.635 | 1,673,690 | 04-24-2024 |
$41.24 | $40.66 | $41.24 | $41.26 | $40.6 | 2,289,896 | 04-23-2024 |
$40.59 | $39.99 | $40.59 | $40.755 | $39.96 | 3,800,880 | 04-22-2024 |
$39.75 | $39.37 | $39.75 | $39.76 | $39.37 | 1,623,882 | 04-19-2024 |
$39.27 | $39.39 | $39.27 | $39.5 | $39.155 | 2,636,945 | 04-18-2024 |
$39.6 | $39.72 | $39.6 | $39.85 | $39.44 | 3,208,339 | 04-17-2024 |
$39.95 | $40.02 | $39.95 | $40.23 | $39.72 | 2,422,869 | 04-16-2024 |
$40.5 | $40.9 | $40.5 | $41.055 | $40.44 | 3,373,753 | 04-15-2024 |
$40.66 | $40.96 | $40.66 | $40.97 | $40.49 | 5,264,697 | 04-12-2024 |
$40.8 | $41 | $40.8 | $41.25 | $40.68 | 2,903,779 | 04-11-2024 |
$40.69 | $40.62 | $40.69 | $40.75 | $40.485 | 4,370,362 | 04-10-2024 |
$40.88 | $40.89 | $40.88 | $40.9589 | $40.67 | 3,191,316 | 04-09-2024 |
$40.85 | $41.08 | $40.85 | $41.08 | $40.821 | 1,856,137 | 04-08-2024 |
$41.19 | $40.59 | $41.19 | $41.25 | $40.535 | 6,093,092 | 04-05-2024 |
$40.86 | $41.73 | $40.86 | $41.88 | $40.84 | 2,634,138 | 04-04-2024 |
$41.54 | $41.5 | $41.54 | $41.74 | $41.325 | 3,048,511 | 04-03-2024 |
$41.79 | $42.13 | $41.79 | $42.14 | $41.67 | 2,582,029 | 04-02-2024 |
$42.42 | $42.74 | $42.42 | $42.87 | $42.225 | 1,515,071 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit ov...
GSK Plc (NYSE:GSK) has reportedly taken legal action against Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) in a...
Drug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the Nuffield Trust reveals. Brexit is cited as a significa...